133 related articles for article (PubMed ID: 32351264)
1. Utility of Short-Acting Intravenous Insulin Therapy in Preparation of F-18 Fluorodeoxyglucose Positron Emission Tomography Computed Tomography Scan in Cancer Patients Incidentally Detected with High Blood Glucose Levels on the Day of Test.
Rallapeta RP; Manthri RG; Kalawat T; Sachan A; Lakshmi AY; Hulikal N
Indian J Nucl Med; 2020; 35(2):110-115. PubMed ID: 32351264
[TBL] [Abstract][Full Text] [Related]
2. Influence of subcutaneous administration of rapid-acting insulin in the quality of (18)F-FDG PET/CT studies.
Garcia JR; Sanchis A; Juan J; Tomas J; Domenech A; Soler M; Moragas M; Riera E
Nucl Med Commun; 2014 May; 35(5):459-65. PubMed ID: 24535382
[TBL] [Abstract][Full Text] [Related]
3. Ultrashort-acting insulin may improve on 18F-FDG PET/CT image quality in patients with uncontrolled diabetic mellitus.
Song HS; Yoon JK; Lee SJ; Yoon SH; Jo KS; An YS
Nucl Med Commun; 2013 Jun; 34(6):527-32. PubMed ID: 23511925
[TBL] [Abstract][Full Text] [Related]
4. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
5. Use of Oral Empagliflozin to Obtain Optimal Blood Sugar Levels for Conducting
Mahato A; Jain A; Prakash VS; Nair R; Joshi R; Paliwal D; Tiwari A; Khandpur S; Singh H
World J Nucl Med; 2023 Sep; 22(3):191-195. PubMed ID: 37854083
[No Abstract] [Full Text] [Related]
6. Assessing oral glucose and intravenous insulin loading protocol in
Sarikaya I; Sharma PN; Sarikaya A; Elgazzar AH
World J Nucl Med; 2020; 19(1):1-7. PubMed ID: 32190015
[TBL] [Abstract][Full Text] [Related]
7. Effect of hyperglycemia on brain and liver
Viglianti BL; Wong KK; Wimer SM; Parameswaran A; Nan B; Ky C; Townsend DM; Rubello D; Frey KA; Gross MD
Biomed Pharmacother; 2017 Apr; 88():1038-1045. PubMed ID: 28192877
[TBL] [Abstract][Full Text] [Related]
8. 18F-2-fluoro-2-deoxyglucose uptake in white adipose tissue on pediatric oncologic positron emission tomography (PET)/computed tomography (CT).
Wong KK; Sedig LK; Bloom DA; Hutchinson RJ; Shulkin BL
Pediatr Radiol; 2020 Apr; 50(4):524-533. PubMed ID: 31776602
[TBL] [Abstract][Full Text] [Related]
9. Proposal for an optimized protocol for intravenous administration of insulin in diabetic patients undergoing (18)F-FDG PET/CT.
Caobelli F; Pizzocaro C; Paghera B; Guerra UP
Nucl Med Commun; 2013 Mar; 34(3):271-5. PubMed ID: 23250295
[TBL] [Abstract][Full Text] [Related]
10. Effects of hyperglycemia on fluorine-18-fluorodeoxyglucose biodistribution in a large oncology clinical practice.
Rosica D; Cheng SC; Hudson M; Sakellis C; Van den Abbeele AD; Kim CK; Jacene HA
Nucl Med Commun; 2018 May; 39(5):417-422. PubMed ID: 29629997
[TBL] [Abstract][Full Text] [Related]
11. Do hyperglycemia and diabetes affect the incidence of false-negative 18F-FDG PET/CT studies in patients evaluated for infection or inflammation and cancer? A Comparative analysis.
Rabkin Z; Israel O; Keidar Z
J Nucl Med; 2010 Jul; 51(7):1015-20. PubMed ID: 20554733
[TBL] [Abstract][Full Text] [Related]
12. Optimization of whole-body positron emission tomography imaging by using delayed 2-deoxy-2-[F-18]fluoro-D: -glucose Injection following I.V. Insulin in diabetic patients.
Turcotte E; Leblanc M; Carpentier A; Bénard F
Mol Imaging Biol; 2006; 8(6):348-54. PubMed ID: 17053859
[TBL] [Abstract][Full Text] [Related]
13. Impact of intravenous insulin on 18F-FDG PET in diabetic cancer patients.
Roy FN; Beaulieu S; Boucher L; Bourdeau I; Cohade C
J Nucl Med; 2009 Feb; 50(2):178-83. PubMed ID: 19164226
[TBL] [Abstract][Full Text] [Related]
14. 18F-FLUORODEOXYGLUCOSE PET/CT CAN BE AN ALTERNATIVE METHOD TO ASSESSMENT OF INSULIN RESISTANCE.
Altun Tuzcu S; Cetin FA; Pekkolay Z; Tuzcu AK
Acta Endocrinol (Buchar); 2019; 15(4):539-543. PubMed ID: 32377256
[TBL] [Abstract][Full Text] [Related]
15. Ferret thoracic anatomy by 2-deoxy-2-(18F)fluoro-D-glucose (18F-FDG) positron emission tomography/computed tomography (18F-FDG PET/CT) imaging.
Wu A; Zheng H; Kraenzle J; Biller A; Vanover CD; Proctor M; Sherwood L; Steffen M; Ng C; Mollura DJ; Jonsson CB
ILAR J; 2012; 53(1):E9-21. PubMed ID: 23382267
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the effect of positive and negative oral contrast agents on (18)F-FDG PET/CT scan.
Sun XG; Huang G; Liu JJ; Wan LR
Hell J Nucl Med; 2009; 12(2):115-8. PubMed ID: 19675862
[TBL] [Abstract][Full Text] [Related]
17.
Parihar AS; Mittal BR; Kumar R; Shukla J; Bhattacharya A
Thyroid; 2020 Apr; 30(4):557-567. PubMed ID: 31870227
[No Abstract] [Full Text] [Related]
18. Impact of blood glucose, diabetes, insulin, and obesity on standardized uptake values in tumors and healthy organs on 18F-FDG PET/CT.
Büsing KA; Schönberg SO; Brade J; Wasser K
Nucl Med Biol; 2013 Feb; 40(2):206-13. PubMed ID: 23228852
[TBL] [Abstract][Full Text] [Related]
19. Does hyperglycemia affect the diagnostic value of 18F-FDG PET/CT?
Mirpour S; Meteesatien P; Khandani AH
Rev Esp Med Nucl Imagen Mol; 2012; 31(2):71-7. PubMed ID: 22088805
[TBL] [Abstract][Full Text] [Related]
20. [The application of (18)F fluorodeoxyglucose-positron emission tomography/computed tomography in the diagnosis and treatment of dermatomyositis].
Pei L; Guan ZW; Ji XJ; Wen QF; Sun F; Zhao Z; Jin JY; Zhu J; Zhang JL; Huang F
Zhonghua Nei Ke Za Zhi; 2016 Jul; 55(7):525-30. PubMed ID: 27373287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
